Diffuse increase in bone density L1-L4 with Z-score of 5.2
Increase in bone density at the left total hip with Z-score of 3.2
Case Description:
42 y old woman with longstanding mastocytosis, comorbidity of papillary thyroid Cancer (pT3,pN1b,Mx). Patient has presented with skin rash and flushing in 2014. Work up revealed elevated tryptase up to 132 mcg/l , c-kit in blood draw was positive, bone marrow biopsy was done, which showed a few mast cells, but no malignant-appearing mast cells.
Credit:
Susanne Trost MD
Clinical Densitometrist
Endocrinology, Diabetes and Metabolism
Assistant Professor
University of Minnesota, Twin Cities
References:
Rama TA, Henriques AF, Matito A, Jara-Acevedo M, Caldas C, Mayado A, Muñoz-González JI, Moreira A, Cavaleiro-Rufo J, García-Montero A, Órfão A, Sanchez-Muñoz L, Álvarez-Twose I. Bone and Cytokine Markers Associated With Bone Disease in Systemic Mastocytosis. J Allergy Clin Immunol Pract. 2023 May;11(5):1536-1547. doi: 10.1016/j.jaip.2023.02.007. Epub 2023 Feb 18. Erratum in: J Allergy Clin Immunol Pract. 2024 Jan;12(1):269. doi: 10.1016/j.jaip.2023.12.014. PMID: 36801493.
Leguit RJ, Wang SA, George TI, Tzankov A, Orazi A. The international consensus classification of mastocytosis and related entities. Virchows Arch. 2023 Jan;482(1):99-112. doi: 10.1007/s00428-022-03423-3. Epub 2022 Oct 10. PMID: 36214901.
Rossini M, Zanotti R, Viapiana O, Tripi G, Orsolini G, Idolazzi L, Bonadonna P, Schena D, Escribano L, Adami S, Gatti D. Bone involvement and osteoporosis in mastocytosis. Immunol Allergy Clin North Am. 2014 May;34(2):383-96. doi: 10.1016/j.iac.2014.01.011. Epub 2014 Mar 13. PMID: 24745681.
Riffel P, Schwaab J, Lutz C, Naumann N, Metzgeroth G, Fabarius A, Schoenberg SO, Hofmann WK, Valent P, Reiter A, Jawhar M. An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis. J Cancer Res Clin Oncol. 2020 Apr;146(4):945-951. doi: 10.1007/s00432-019-03119-3. Epub 2020 Jan 24. PMID: 31980928; PMCID: PMC7085471.